Get notified when NRXS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Dilution In Net Tangible Book Value Per Share to New Investors $1.80 (new) — New investors will experience immediate dilution of $1.80 per share, representing a 74% dilution relative to the $2.42 offering price.
- No Minimum Offering Amount Required (new) — The company may sell no shares at all, making the actual proceeds uncertain and potentially insufficient to fund its intended uses.
Neuraxis launches at-the-market offering to sell up to $3.3M of common stock at $2.42/share
Filed August 29, 2025 · ~2 min read
Key Changes
-
high
Neuraxis may sell up to $3.3 million of common stock in an at-the-market offering through Craig-Hallum, with no minimum amount required.
The Offering verify on EDGAR → -
medium
The offering price is $2.42 per share, the last reported sale price on NYSE American on August 27, 2025, used for illustrative calculations.
The Offering verify on EDGAR → -
high
New investors face immediate dilution of $1.80 per share, based on an as-adjusted net tangible book value of $0.62 per share after the offering.
Dilution verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade NRXS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify